Ann Lab Med.  2015 Jan;35(1):62-68. 10.3343/alm.2015.35.1.62.

Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based VITEK MS System for the Identification of Acinetobacter Species from Blood Cultures: Comparison with VITEK 2 and MicroScan Systems

Affiliations
  • 1Department of Laboratory Medicine, Chonnam National University Medical School, Gwangju, Korea. shinjh@chonnam.ac.kr

Abstract

BACKGROUND
Acinetobacter species are the leading cause of bloodstream infection (BSI), but their correct identification is challenging. We evaluated the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based VITEK MS (bioMerieux, France), and two automated systems, VITEK 2 (bioMerieux) and MicroScan (Siemens, USA) for identification of Acinetobacter BSI isolates.
METHODS
A total of 187 BSI isolates recovered at a university hospital in Korea between 2010 and 2012 were analyzed. The identification results obtained using VITEK MS and two automated systems were compared with those of rpoB sequencing.
RESULTS
Of 187 isolates analyzed, 176 were identified to the species level by rpoB sequencing: the Acinetobacter baumannii group (ABG; 101 A. baumannii, 43 A. nosocomialis, 10 A. pittii isolates) was most commonly identified (82.4%), followed by Acinetobacter genomic species 13BJ/14TU (5.3%), A. ursingii (2.1%), A. soli (2.1%), A. bereziniae (1.1%), and A. junii (1.1%). Correct identification rates to the species group (ABG) level or the species level was comparable among the three systems (VITEK MS, 90.3%; VITEK 2, 89.2%; MicroScan, 86.9%). However, VITEK MS generated fewer misidentifications (0.6%) than VITEK 2 (10.8%) and MicroScan (13.1%) (P<0.001). In addition, VITEK MS demonstrated higher specificity (100%) for discrimination between ABG and non-ABG isolates than the other systems (both, 31.8%) (P<0.001).
CONCLUSIONS
The VITEK MS system is superior to the VITEK 2 and MicroScan systems for identification of Acinetobacter BSI isolates, with fewer misidentifications and better discrimination between the ABG and non-ABG isolates.

Keyword

VITEK MS; VITEK 2; MicroScan; Acinetobacter; Identification

MeSH Terms

Acinetobacter/*genetics/isolation & purification
Acinetobacter Infections/diagnosis/microbiology
Bacterial Proteins/genetics
Bacterial Typing Techniques/*instrumentation/*methods
Blood/*microbiology
DNA, Bacterial/*analysis/metabolism
Databases, Genetic
Humans
*Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Bacterial Proteins
DNA, Bacterial

Cited by  1 articles

새로운 MALDI-TOF질량분석기 ASTA MicroIDSys의 Acinetobacter 종 동정에 관한 성능 평가: Bruker Biotyper와의 비
Wooshin Kim, Ho Jong Lee, Seulbi Lee, Choon-Mee Kim, Jong Hee Shin, Soo Hyun Kim, Young Jin Ko, Seong-Ho Kang, Geon Park, Sook Jin Jang
Lab Med Online. 2022;12(3):183-190.    doi: 10.47429/lmo.2022.12.3.183.


Reference

1. Chuang YC, Sheng WH, Li SY, Lin YC, Wang JT, Chen YC, et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin Infect Dis. 2011; 52:352–360. PMID: 21193494.
2. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008; 21:538–582. PMID: 18625687.
3. Turton JF, Shah J, Ozongwu C, Pike R. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J Clin Microbiol. 2010; 48:1445–1449. PMID: 20181894.
4. Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen Ø. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother. 2011; 66:738–744. PMID: 21393175.
5. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007; 5:939–951. PMID: 18007677.
6. Kim D, Baik KS, Kim MS, Park SC, Kim SS, Rhee MS, et al. Acinetobacter soli sp. nov., isolated from forest soil. J Microbiol. 2008; 46:396–401. PMID: 18758729.
7. Nemec A, Musílek M, Maixnerová M, De Baere T, van der Reijden TJ, Vaneechoutte M, et al. Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans. Int J Syst Evol Microbiol. 2009; 59:118–124. PMID: 19126734.
8. Vaneechoutte M, De Baere T, Nemec A, Musílek M, van der Reijden TJ, Dijkshoorn L. Reclassification of Acinetobacter grimontii Carr et al. 2003 as a later synonym of Acinetobacter junii Bouvet and Grimont 1986. Int J Syst Evol Microbiol. 2008; 58:937–940. PMID: 18398198.
9. Wisplinghoff H, Paulus T, Lugenheim M, Stefanik D, Higgins PG, Edmond MB, et al. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. J Infect. 2012; 64:282–290. PMID: 22209744.
10. Kishii K, Kikuchi K, Matsuda N, Yoshida A, Okuzumi K, Uetera Y, et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for species identification of Acinetobacter strains isolated from blood cultures. Clin Microbiol Infect. 2014; 20:424–430. PMID: 24125498.
11. Lee SY, Shin JH, Park KH, Kim JH, Shin MG, Suh SP, et al. Identification, genotypic relation, and clinical features of colistin-resistant isolates of Acinetobacter genomic species 13BJ/14TU from bloodstreams of patients in a university hospital. J Clin Microbiol. 2014; 52:931–939. PMID: 24403305.
12. Lee YC, Huang YT, Tan CK, Kuo YW, Liao CH, Lee PI, et al. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J Antimicrob Chemother. 2011; 66:1839–1846. PMID: 21653602.
13. Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J. 2011; 52:879–891. PMID: 22028150.
14. Bernards AT, van der Toorn J, van Boven CP, Dijkshoorn L. Evaluation of the ability of a commercial system to identify Acinetobacter genomic species. Eur J Clin Microbiol Infect Dis. 1996; 15:303–308. PMID: 8781881.
15. Dubois D, Grare M, Prere MF, Segonds C, Marty N, Oswald E. Performances of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology. J Clin Microbiol. 2012; 50:2568–2576. PMID: 22593596.
Article
16. Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, et al. Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur J Clin Microbiol Infect Dis. 2014; 33:337–346. PMID: 24019163.
17. Khamis A, Raoult D, La Scola B. rpoB gene sequencing for identification of Corynebacterium species. J Clin Microbiol. 2004; 42:3925–3931. PMID: 15364970.
18. La Scola B, Gundi VA, Khamis A, Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol. 2006; 44:827–832. PMID: 16517861.
19. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology. 2009; 155:2333–2341. PMID: 19389786.
20. Won EJ, Shin JH, Lee K, Kim MN, Lee HS, Park YJ, et al. Accuracy of species-level identification of yeast isolates from blood cultures from 10 university hospitals in South Korea by use of the matrix-assisted laser desorption ionization-time of flight mass spectrometry-based Vitek MS system. J Clin Microbiol. 2013; 51:3063–3065. PMID: 23784123.
Article
21. Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol. 1991; 29:277–282. PMID: 2007635.
22. Seifert H, Strate A, Schulze A, Pulverer G. Bacteremia due to Acinetobacter species other than Acinetobacter baumannii. Infection. 1994; 22:379–385. PMID: 7698833.
23. Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis. 2008; 27:607–612. PMID: 18283503.
24. Šedo O, Nemec A, Křížová L, Kačalová M, Zdráhal Z. Improvement of MALDI-TOF MS profiling for the differentiation of species within the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Syst Appl Microbiol. 2013; 36:572–578. PMID: 24054697.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr